 Ovid Therapeutics Inc NASDAQ:OVID gapped up before the market opened on Friday after Cantor Fitzgerald raised their price target on the stock from 7.00 to 13.00. The stock had previously closed at 8.99, but opened at 7.37. Cantor Fitzgerald currently has an overweight rating on the stock. Ovid Therapeutics shares last traded at 7.17, with ... 